ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)
To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia#1185953
- D-serine Monotherapy for Schizophrenia#884301
- RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder#1246658
- Role of Vitamin D Supplementation in Schizophrenia#859913
- Optimization of Treatment and Management of Schizophrenia in Europe#1186231
Record · ID 1364245
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive